Insider filing · REPL
Kapil Dhingra
Director
profile →
Replimune Group, Inc.
REPL · Healthcare · 11 filings in 24 months
ticker →
Kapil Dhingra sold $408K of Replimune (REPL)
Executed Nov 2, disclosed Nov 4, 1 day later.
Value, as filed
$408K
21,500 sh × $19.00
Executed
Nov 2
the trade date, as filed
Disclosed
Nov 4
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KDKapil Dhingra (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Replimune Group, Inc. (REPL). The largest single filing was $408K of REPL (21,500 sh × $19.00, as filed), executed Nov 2.
The name
REPLHealthcare · Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapie…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→